Top biotech deals in October 2026
The most expensive biotech M&A in October 2026 was worth $2 billion. Licensing deals spanned across therapeutic technologies.
The most expensive biotech M&A in October 2026 was worth $2 billion. Licensing deals spanned across therapeutic technologies.